Literature DB >> 18412061

The role of neuroimaging for the diagnosis and treatment of anxiety disorders.

Martin P Paulus1.   

Abstract

Neuroimaging comprises a set of tools, which include different types of magnetic resonance imaging such as functional magnetic resonance imaging (fMRI), Magnetic Resonance Spectroscopy (MRS), Arterial Spin Labeling (ASL), and radiotracer imaging such as positron emission tomography and single photon emission computed tomography. The focus of this review is to address the question whether fMRI can contribute to the diagnosis and treatment of anxiety disorders. Key anxiety processes and neural substrates are reviewed. The main findings and shortcomings of fMRI in the context of anxiety are briefly summarized. Finally, the next stages of developing fMRI for diagnosis and treatment are highlighted. The main conclusion of this review is that fMRI could become a clinical tool for the diagnosis and treatment of anxiety disorders, but neuroimaging groups will need to better develop its specificity and sensitivity so that fMRI results can be meaningful for an individual patient not just for groups of individuals.

Entities:  

Mesh:

Year:  2008        PMID: 18412061      PMCID: PMC4429203          DOI: 10.1002/da.20499

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  96 in total

1.  A comparative fMRI study of cortical representations for thermal painful, vibrotactile, and motor performance tasks.

Authors:  P A Gelnar; B R Krauss; P R Sheehe; N M Szeverenyi; A V Apkarian
Journal:  Neuroimage       Date:  1999-10       Impact factor: 6.556

2.  Explicit and incidental facial expression processing: an fMRI study.

Authors:  M L Gorno-Tempini; S Pradelli; M Serafini; G Pagnoni; P Baraldi; C Porro; R Nicoletti; C Umità; P Nichelli
Journal:  Neuroimage       Date:  2001-08       Impact factor: 6.556

3.  The anterior frontomedian cortex and evaluative judgment: an fMRI study.

Authors:  Stefan Zysset; Oswald Huber; Evelyn Ferstl; D Yves von Cramon
Journal:  Neuroimage       Date:  2002-04       Impact factor: 6.556

4.  Neocortical modulation of the amygdala response to fearful stimuli.

Authors:  Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Francesco Fera; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2003-03-15       Impact factor: 13.382

5.  Effect of task conditions on brain responses to threatening faces in social phobics: an event-related functional magnetic resonance imaging study.

Authors:  Thomas Straube; Iris-Tatjana Kolassa; Madlen Glauer; Hans-Joachim Mentzel; Wolfgang H R Miltner
Journal:  Biol Psychiatry       Date:  2004-12-15       Impact factor: 13.382

6.  A contemporary learning theory perspective on the etiology of anxiety disorders: it's not what you thought it was.

Authors:  Susan Mineka; Richard Zinbarg
Journal:  Am Psychol       Date:  2006-01

7.  Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia.

Authors:  K Luan Phan; Daniel A Fitzgerald; Pradeep J Nathan; Manuel E Tancer
Journal:  Biol Psychiatry       Date:  2005-10-26       Impact factor: 13.382

8.  A neuromodulatory role for the human amygdala in processing emotional facial expressions.

Authors:  J S Morris; K J Friston; C Büchel; C D Frith; A W Young; A J Calder; R J Dolan
Journal:  Brain       Date:  1998-01       Impact factor: 13.501

Review 9.  The overprediction of fear: a review.

Authors:  S Rachman
Journal:  Behav Res Ther       Date:  1994-09

Review 10.  Neuroanatomical circuits modulating fear and anxiety behaviors.

Authors:  D S Charney
Journal:  Acta Psychiatr Scand Suppl       Date:  2003
View more
  9 in total

1.  Common and dissociable effects of oxytocin and lorazepam on the neurocircuitry of fear.

Authors:  Ann-Kathrin Kreuder; Dirk Scheele; Johannes Schultz; Juergen Hennig; Nina Marsh; Torge Dellert; Ulrich Ettinger; Alexandra Philipsen; Mari Babasiz; Angela Herscheid; Laura Remmersmann; Ruediger Stirnberg; Tony Stöcker; René Hurlemann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-08       Impact factor: 11.205

2.  Advances in the diagnosis of anorexia nervosa and bulimia nervosa using brain imaging.

Authors:  Guido K W Frank
Journal:  Expert Opin Med Diagn       Date:  2012-05-01

Review 3.  Anxiety in mice and men: a comparison.

Authors:  Christa Hohoff
Journal:  J Neural Transm (Vienna)       Date:  2009-04-02       Impact factor: 3.575

4.  Early life stress and the anxious brain: evidence for a neural mechanism linking childhood emotional maltreatment to anxiety in adulthood.

Authors:  G A Fonzo; H J Ramsawh; T M Flagan; A N Simmons; S G Sullivan; C B Allard; M P Paulus; M B Stein
Journal:  Psychol Med       Date:  2015-12-16       Impact factor: 7.723

Review 5.  Neuroimaging and Anxiety: the Neural Substrates of Pathological and Non-pathological Anxiety.

Authors:  James M Taylor; Paul J Whalen
Journal:  Curr Psychiatry Rep       Date:  2015-06       Impact factor: 5.285

Review 6.  Neuroimaging in anxiety disorders.

Authors:  Kathrin Holzschneider; Christoph Mulert
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

7.  The Utility of an Anxiety Screening Measure in Youth With Functional Abdominal Pain Disorders and Clinical Characteristics Associated With Presence of Anxiety.

Authors:  Richa Aggarwal Dutta; Samantha L Ely; Natoshia R Cunningham
Journal:  Clin J Pain       Date:  2021-08-01       Impact factor: 3.423

8.  Gray Matter Alterations in Post-Traumatic Stress Disorder, Obsessive-Compulsive Disorder, and Social Anxiety Disorder.

Authors:  Bochao Cheng; Xiaoqi Huang; Shiguang Li; Xinyu Hu; Ya Luo; Xiuli Wang; Xun Yang; Changjian Qiu; Yanchun Yang; Wei Zhang; Feng Bi; Neil Roberts; Qiyong Gong
Journal:  Front Behav Neurosci       Date:  2015-08-20       Impact factor: 3.558

9.  Clinical characteristics of patients with persistent postural-perceptual dizziness.

Authors:  Roseli Saraiva Moreira Bittar; Eliane Maria Dias von Söhsten Lins
Journal:  Braz J Otorhinolaryngol       Date:  2014-09-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.